Ignite Creation Date:
2024-05-06 @ 7:42 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06105008
Status:
WITHDRAWN
Last Update Posted:
2024-02-21
First Post:
2023-10-23
Brief Title:
Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive HER2-low Locally Advanced or Metastatic Breast Cancer
Sponsor:
RemeGen Co Ltd
Organization:
RemeGen Co Ltd